Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;7(6):415-428.
doi: 10.1016/S2352-4642(22)00381-9. Epub 2023 Mar 9.

Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents

Affiliations
Review

Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents

Margaret H Sibley et al. Lancet Child Adolesc Health. 2023 Jun.

Abstract

Attention-deficit hyperactivity disorder (ADHD) affects approximately 5% of children and adolescents globally and is associated with negative life outcomes and socioeconomic costs. First-generation ADHD treatments were predominantly pharmacological; however, increased understanding of biological, psychological, and environmental factors contributing to ADHD has expanded non-pharmacological treatment possibilities. This Review provides an updated evaluation of the efficacy and safety of non-pharmacological treatments for paediatric ADHD, discussing the quality and level of evidence for nine intervention categories. Unlike medication, no non-pharmacological treatments showed a consistent strong effect on ADHD symptoms. When considering broad outcomes (eg, impairment, caregiver stress, and behavioural improvement), multicomponent (cognitive) behaviour therapy joined medication as a primary ADHD treatment. With respect to secondary treatments, polyunsaturated fatty acids showed a consistent modest effect on ADHD symptoms when taken for at least 3 months. Additionally, mindfulness and multinutrient supplementation with four or more ingredients showed modest efficacy on non-symptom outcomes. All other non-pharmacological treatments were safe; clinicians might tolerate their use but should educate families of childrenand adolescents with ADHD on the disadvantages, including costs, burden to the service user, absence of proven efficacy relative to other treatments, and delay of proven treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests MHS receives royalties from Guilford Press and has received honoraria from Supernus Pharmaceuticals, and serves as the secretary of the American Professional Society for ADHD and related disorders. JMJ's research received donated products from Hardy Nutritionals and Truehope. JM receives royalties from Guilford Press and consulting fees from Myndlift. JM also receives research funding from the Templeton Foundation and the Duke Center for AIDS research. LEA receives research funding from Roche, Axial, Syneos, Supernus, and Myndlift, and the Foundation for Mental Health. LEA has received consulting fees and support for meeting attendance from Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD). LEA's research has received an equipment loan from Myndlift and donated products from Hardy Nutritionals. All other authors report no competing interests.

Figures

Figure 1:
Figure 1:. A theoretical model of factors that influence ADHD severity and the treatments that target them
ADHD treatments and the mechanisms that they are proposed to target are illustrated. Level of evidence for the effect of treatments on targets are summarised in the appendix (pp 120–237). BT=behaviour therapy. GABA=γ-aminobutyric-acid.
Figure 2:
Figure 2:. Venn diagrams representing components of behaviour therapy interventions
Operant reinforcement was present in almost all behaviour therapy packages (90·2%), as was parent skills training (82·4%). Youth (55·9%) and teacher (18·6%) skills training were less common. Youth skills training included social (30·4%), problem-solving (30·4%), organisation (28·4%), and metacognitive (13·7%) skills. Motivational interviewing, an engagement strategy, was bundled into 6·9% of packages. On average, treatments possessed approximately three components. Numbers indicate the number of intervention packages that have that component.

References

    1. Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. Washington, DC: American Psychiatric Publishing, 2013.
    1. Hechtman L, Swanson JM, Sibley MH, et al. Functional adult outcomes 16 years after childhood diagnosis of attention-deficit/ hyperactivity disorder: MTA results. J Am Acad Child Adolesc Psychiatry 2016; 55: 945–52. - PMC - PubMed
    1. Altszuler AR, Page TF, Gnagy EM, et al. Financial dependence of young adults with childhood ADHD. J Abnorm Child Psychol 2016; 44: 1217–29. - PMC - PubMed
    1. Bagwell CL, Molina BS, Pelham WE Jr, Hoza B. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40: 1285–92. - PubMed
    1. Kuriyan AB, Pelham WE Jr, Molina BSG, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol 2013; 41: 27–41. - PMC - PubMed